Biodegradable drug-eluting poly[lactic-co-glycol acid] nanofibers for the sustainable delivery of vancomycin to brain tissue: In vitro and in vivo studies

ACS Chemical Neuroscience

Volumn 4, Issue 9, 2013, Pages 1314-1321

  Tseng, Yuan Yun ^a,b,c   Kao, Yu Chun ^c   Liao, Jun Yi ^c   Chen, Wei An ^c   Liu, Shih Jung ^c  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

biodegradable; Brain abscess; cerebral infection; nanofibers; poly lactic co glycol acid ; vancomycin

Indexed keywords

NANOFIBER; POLYGLACTIN; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INFECTION; BRAIN MEMBRANE; BRAIN TISSUE; CONTROLLED STUDY; CRANIECTOMY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RELEASE; ELECTROSPINNING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOLOGY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ABSORBABLE IMPLANTS; ABSORPTION; ANIMALS; ANTI-BACTERIAL AGENTS; BRAIN; BRAIN ABSCESS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COMBINED MODALITY THERAPY; DRUG CARRIERS; DRUG EVALUATION, PRECLINICAL; DRUG IMPLANTS; LACTIC ACID; MEMBRANES, ARTIFICIAL; NANOFIBERS; POLYGLYCOLIC ACID; POROSITY; RANDOM ALLOCATION; RATS; VANCOMYCIN; WOUND HEALING;

EID: 84884372707     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/cn400108q     Document Type: Article

References (44)

1. McClelland, S., III and Hall, W. A. (2007) Postoperative central nervous system infection: Incidence and associated factors in 2111 neurosurgical procedures Clin. Infect. Dis. 45 (1) 55-59
2. Moorthy, R. K. and Rajshekhar, V. (2008) Management of brain abscess: An overview Neurosurg. Focus 24 (6) E3
3. Bernardini, G. L. (2004) Diagnosis and management of brain abscess and subdural empyema Curr. Neurol. Neurosci. Rep. 4 (6) 448-456
4. Cavusoglu, H., Kaya, R. A., Turkmenoglu, O. N., Colak, I., and Aydin, Y. (2008) Brain abscess: Analysis of results in a series of 51 patients with a combined surgical and medical approach during an 11-year period Neurosurg. Focus 24 (6) E9
5. Mampalam, T. J. and Rosenblum, M. L. (1988) Trends in the management of bacterial brain abscesses: A review of 102 cases over 17 years Neurosurgery 23 (4) 451-458
6. Rosenblum, M. L., Hoff, J. T., Norman, D., Edwards, M. S., and Berg, B. O. (1980) Nonoperative treatment of brain abscesses in selected high-risk patients J. Neurosurg. 52 (2) 217-225
7. Duma, C. M., Kondziolka, D., and Lunsford, L. D. (1992) Image-guided stereotactic management of non-AIDS-related cerebral infection Neurosurg. Clin. North Am. 3 (2) 291-302
8. Kutlay, M., Colak, A., Yildiz, S., Demircan, N., and Akin, O. N. (2005) Stereotactic aspiration and antibiotic treatment combined with hyperbaric oxygen therapy in the management of bacterial brain abscesses Neurosurgery 57 (6) 1140-1146
9. Stephanov, S. (1988) Surgical treatment of brain abscess Neurosurgery 22 (4) 724-730
10. Su, T. M., Lan, C. M., Tsai, Y. D., Lee, T. C., Lu, C. H., and Chang, W. N. (2008) Multiloculated pyogenic brain abscess: Experience in 25 patients Neurosurgery 62 (Suppl. 2) 556-561
11. Korinek, A. M., Golmard, J. L., Elcheick, A., Bismuth, R., van Effenterre, R., Coriat, P., and Puybasset, L. (2005) Risk factors for neurosurgical site infections after craniotomy: A critical reappraisal of antibiotic prophylaxis on 4,578 patients Br. J. Neurosurg. 19 (2) 155-162
12. Tunkel, A. R., Hartman, B. J., Kaplan, S. L., Kaufman, B. A., Roos, K. L., Scheld, W. M., and Whitley, R. J. (2004) Practice guidelines for the management of bacterial meningitis Clin. Infect. Dis. 39 (9) 1267-1284
13. Liu, C., Bayer, A., Cosgrove, S. E., Daum, R. S., Fridkin, S. K., Gorwitz, R. J., Kaplan, S. L., Karchmer, A. W., Levine, D. P., Murray, B. E., Rybak, M. J., Talan, D. A., and Chambers, H. F. (2011) Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children Clin. Infect. Dis. 52 (3) e18-e55
14. Wang, Q., Shi, Z., Wang, J., Shi, G., Wang, S., and Zhou, J. (2008) Postoperatively administered vancomycin reaches therapeutic concentration in the cerebral spinal fluid of neurosurgical patients Surg. Neurol. 69 (2) 126-129
15. American Society of Health-System Pharmacists (1988) (ASHP) therapeutic position statement on the preferential use of metronidazole for the treatment of Clostridium difficile -associated disease Am. J. Health Syst. Pharm. 55 (13) 1407-1411
16. Yang, S. Y. (1981) Brain abscess: A review of 400 cases J. Neurosurg. 55 (5) 794-799
17. Tseng, J. H. and Tseng, M. Y. (2006) Brain abscess in 142 patients: Factors influencing outcome and mortality Surg. Neurol. 65 (6) 557-562
18. Korinek, A. M., Baugnon, T., Golmard, J. L., van Effenterre, R., Coriat, P., and Puybasset, L. (2006) Risk factors for adult nosocomial meningitis after craniotomy: Role of antibiotic prophylaxis Neurosurgery 59 (1) 126-133
19. Stone, P. A., Armstrong, P. A., Bandyk, D. F., Brumberg, R. S., Flaherty, S. K., Back, M. R., Johnson, B. L., and Shames, M. L. (2006) Use of antibiotic-loaded polymethylmethacrylate beads for the treatment of extracavitary prosthetic vascular graft infections J. Vasc. Surg. 44 (4) 757-761
20. Xie, Z., Liu, X., Jia, W., Zhang, C., Huang, W., and Wang, J. (2009) Treatment of osteomyelitis and repair of bone defect by degradable bioactive borate glass releasing vancomycin J. Controlled Release 139 (2) 118-126
21. Kanellakopoulou, K. and Giamarellos-Bourboulis, E. J. (2000) Carrier systems for the local delivery of antibiotics in bone infections Drugs 59 (6) 1223-1232
22. Shi, M., Kretlow, J. D., Nguyen, A., Young, S., Baggett, L. S., Wong, M. E., Kasper, F. K., and Mikos, A. G. (2010) Antibiotic-releasing porous polymethylmethacrylate constructs for osseous space maintenance and infection control Biomaterials 31 (14) 4146-4156
23. El-Husseiny, M., Patel, S., MacFarlane, R. J., and Haddad, F. S. (2011) Biodegradable antibiotic delivery systems J. Bone Joint Surg. Br. 93 (2) 151-157
24. Liu, S. J., Ueng, S. W.-N., Lin, S. S., and Chan, E. C. (2002) In vivo release of vancomycin from biodegradable beads J. Biomed. Mater. Res. 63 (6) 807-813
25. Le Ray, A. M., Chiffoleau, S., Iooss, P., Grimandi, G., Gouyette, A., Daculsi, G., and Merle, C. (2003) Vancomycin encapsulation in biodegradable poly(ε-caprolactone) microparticles for bone implantation. Influence of the formulation process on size, drug loading, in vitro release and cytocompatibility Biomaterials 24 (3) 443-449
26. Soriano, A., Marco, F., Martinez, J. A., Pisos, E., Almela, M., Dimova, V. P., Alamo, D., Ortega, M., Lopez, J., and Mensa, J. (2008) Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia Clin. Infect. Dis. 46 (2) 193-200
27. Rybak, M. J., Lomaestro, B. M., Rotschafer, J. C., Moellering, R. C., Jr., Craig, W. A., Billeter, M., Dalovisio, J. R., and Levine, D. P. (2009) Therapeutic monitoring of vancomycin in adults: Summary of consensus recommendations from the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists Pharmacotherapy 29 (11) 1275-1279
28. Patel, N., Pai, M. P., Rodvold, K. A., Lomaestro, B., Drusano, G. L., and Lodise, T. P. (2011) Vancomycin: We can't get there from here Clin. Infect. Dis. 52 (8) 969-974
29. Nicasio, A. M., Bulitta, J. B., Lodise, T. P., D'Hondt, R. E., Kulawy, R., Louie, A., and Drusano, G. L. (2012) Evaluation of once-daily vancomycin against methicillin-resistant Staphylococcus aureus in a hollow-fiber infection model Antimicrob. Agents Chemother. 56 (2) 682-686
30. Rybak, M. J. (2006) The pharmacokinetic and pharmacodynamic properties of vancomycin Clin. Infect. Dis. 42 (Suppl. 1) S35-S39
31. Albanese, J., Leone, M., Bruguerolle, B., Ayem, M. L., Lacarelle, B., and Martin, C. (2000) Cerebrospinal fluid penetration and pharmacokinetics of vancomycin administered by continuous infusion to mechanically ventilated patients in an intensive care unit Antimicrob. Agents Chemother. 44 (5) 1356-1358
32. Sakoulas, G., Moise-Broder, P. A., Schentag, J., Forrest, A., Moellering, R. C., Jr., and Eliopoulos, G. M. (2004) Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia J. Clin. Microbiol. 42 (6) 2398-2402
33. Lodise, T. P., Patel, N., Lomaestro, B. M., Rodvold, K. A., and Drusano, G. L. (2009) Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients Clin. Infect. Dis. 49 (4) 507-514
34. Kreuter, J. and Gelperina, S. (2008) Use of nanoparticles for cerebral cancer Tumori 94 (2) 271-277
35. Olivier, J. C. (2005) Drug transport to brain with targeted nanoparticles NeuroRx 2 (1) 108-119
36. Decuzzi, P., Pasqualini, R., Arap, W., and Ferrari, M. (2009) Intravascular delivery of particulate systems: Does geometry really matter? Pharm. Res. 26 (1) 235-243
37. Chen, D. W., Hsu, Y.-H., Liao, J.-Y., Liu, S. J., Chen, J.-K., and Ueng, S. W.-N. (2012) Sustainable release of vancomycin, gentamicin and lidocaine from novel electrospun sandwich-structured PLGA/collagen nanofibrous membranes Int. J. Pharm. 430 (1-2) 335-341
38. Fournier, E., Passirani, C., Montero-Menei, C. N., and Benoit, J. P. (2003) Biocompatibility of implantable synthetic polymeric drug carriers: Focus on brain biocompatibility Biomaterials 24 (19) 3311-3331
39. Wu, L. and Ding, J. (2004) In vitro degradation of three-dimensional porous poly(d, l -lactide- co -glycolide) scaffolds for tissue engineering Biomaterials 25 (27) 5821-5830
40. Mi, F. L., Lin, Y. M., Wu, Y. B., Shyu, S. S., and Tsai, Y. H. (2002) Chitin/PLGA blend microspheres as a biodegradable drug-delivery system: Phase-separation, degradation and release behavior Biomaterials 23 (15) 3257-3267
41. Chen, D. W., Liao, J. Y., Liu, S. J., and Chan, E. C. (2012) Novel biodegradable sandwich-structured nanofibrous drug-eluting membranes for repair of infected wounds: An in vitro and in vivo study Int. J. Nanomed. 7, 763-771
42. Beduneau, A., Saulnier, P., and Benoit, J. P. (2007) Active targeting of brain tumors using nanocarriers Biomaterials 28 (33) 4947-4967
43. Barbu, E., Molnar, E., Tsibouklis, J., and Gorecki, D. C. (2009) The potential for nanoparticle-based drug delivery to the brain: Overcoming the blood-brain barrier Expert Opin. Drug Delivery 6 (6) 553-565
44. Liu, S. J., Kau, Y. C., Liaw, C. W., and Peng, Y. J. (2009) In vitro elution of vancomycin/amikacin/steroid from solvent-free biodegradable scleral plugs Int. J. Pharm. 370 (1-2) 75-80